Translate
Avidity Biosciences Inc
About
Avidity Biosciences Inc (NASDAQ:RNA) — investor relations, events, news, and company updates on 6ix.
Latest News
Feb 26 2026
Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Feb 18 2026
The New England Journal of Medicine Publishes Results from Phase 1/2 MARINA® Trial of Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1
Feb 2 2026
Avidity Biosciences Announces Expected Record Date for Spin-Off
Nov 19 2025
Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44
Nov 10 2025
Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights
Financials
Revenue
$18.62 M
Market Cap
$212.87 M
EPS
-4.49
